Corline Biomedical AB announced earnings results for the fourth quarter ended December 31, 2020. For the fourth quarter, the company announced total revenue was SEK 5.512 million compared to SEK 4.053 million a year ago. Operating loss was SEK 55,000 compared to SEK 2.116 million a year ago. Net loss was SEK 55,000 compared to SEK 2.116 million a year ago. Basic eps - continuing operations was SEK 0 compared to basic loss per share from continuing operations of SEK 0.13 a year ago. For the full year, total revenue was SEK 15.104 million compared to SEK 11.953 million a year ago. Operating loss was SEK 7.287 million compared to SEK 9.540 million a year ago. Net loss was SEK 7.287 million compared to SEK 9.540 million a year ago.